Back to Rankings

CATX

Perspective TherapeuticsD
NYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
Current thesis
Primary-source evidence shows VMT-α-NET remains the core value driver: interim April 2026 data added follow-up, reported a 43% objective response rate in the first 23 Cohort 2 patients, and described the program as well tolerated, while management signaled more data and regulatory engagement this year [#PR-2026-04-20] [#8-K-2026-04-20].
Posture
Defensive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +18.2.
What can break
Early clinical activity may not hold up as more Cohort 2 and Cohort 3 patients mature, and preliminary responses may not convert into durable or registrationally relevant outcomes [#PR-2026-04-20] [#10-K-2026-03-16].
Momentum
20
Value
42
Sentiment
77
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.25 · Bull $8.50 · Bear $2.00
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-28 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $13.33
Why
Momentum20 · Δ7d +3.1
Value42 · Δ7d +0.0
Sentiment77 · Δ7d +18.2
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
20
34% active weight
Current posture
7d trendSoftening
Δ7d
+3.1
Δ21d
+5.0
Value
42
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.2
Sentiment
77
33% active weight
Current posture
7d trendImproving
Δ7d
+18.2
Δ21d
+13.5
Why this grade

Composite grade D. Momentum 20.4 / Value 41.9 / Sentiment 77.1

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$410.57M
Beta
1.75
Shares Out
74.34M
P/E (TTM) · Derived
-4.5
P/S (TTM)
188.78
P/FCF (TTM) · Derived
-3.77
Rev YoY
-43.4%
EPS YoY
-63.3%
Gross Margin
-
Op Margin
-11043.4%
Net Debt
-$225.24M
Current Ratio
8.66
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology